EORTC classification for primary cutaneous lymphomas: A proposal from the cutaneous lymphoma study group of the European organization for research and treatment of cancer

Blood

Volumn 90, Issue 1, 1997, Pages 354-371

  Willemze, R ^a   Kerl, H ^b   Sterry, W ^b   Berti, E ^b   Cerroni, L ^b   Chimenti, S ^b   Diaz Perez J L ^b   Geerts, M L ^b   Goos, M ^b   Knobler, R ^b   Ralfkiaer, E ^b   Santucci, M ^b   Smith, N ^b   Wechsler, J ^b   Van Vloten, W A ^b   Meijer, C J L M ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER REGISTRY; CANCER RESEARCH; CANCER SURVIVAL; CLINICAL EXAMINATION; EUROPE; HEALTH CARE ORGANIZATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SKIN LYMPHOMA;

HUMANS; LYMPHOMA; SKIN NEOPLASMS;

EID: 0031007614     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (130)

1. Isaacson PG, Norton AJ: Cutaneous lymphoma, in Extranodal Lymphomas. London, Churchill Livingstone, 1994, p 172
2. Weinstock MA, Horn JW: Mycosis fungoides in the United States: Increasing incidence and descriptive epidemiology. JAMA 260:42, 1988
3. Evans H, Winkelmann R, Banks P: Differential diagnosis of malignant and benign cutaneous infiltrates. Cancer 44:699, 1979
4. Burke JS, Hoppe RT, Cibull ML, Dorfman RF: Cutaneous malignant lymphoma. A pathologic study of 50 cases with clinical analysis of 37. Cancer 47:300, 1981
5. Stansfeld AG, Diebold J, Kapanci Y, Kelenyi G, Lennert K, Mioduszewska O, Noel H, Rilke F, Sundstrom C, van Unnik J, Wright D: Updated Kiel classification for lymphomas. Lancet 1:292, 1988
6. Non-Hodgkin's lymphoma pathologic classification project. National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas: Summary and description of a Working Formulation for clinical usage. Cancer 49:2112, 1982
7. Kaudewitz P, Stein H, Dallenbach F. Primary and secondary Ki-1+ (CD30+) anaplastic large cell lymphomas. Am J Pathol 135:1169, 1989
8. Beljaards RC, Kaudewitz P, Berti E, Gianotti R, Neumann C, Rosso R, Paulli M, Meijer CJLM, Willemze R: Primary cutaneous CD30-positive large cell lymphoma: Definition of a new type of cutaneous lymphoma with a favorable prognosis. A European multicenter study on 47 cases. Cancer 71:2097, 1993
9. Willemze R, Meijer CJLM, Scheffer E, Kluin PM, van Vloten WA, Toonstra J, van der Putte SCJ: Diffuse large cell lymphomas of follicular center cell origin presenting in the skin. A clinicopathologic and immunologic study of 16 patients. Am J Pathol 126:325, 1987
10. Santucci M, Pimpinelli N: Cutaneous B-cell lymphoma: A SALT-related tumor, in Lambert WC, Giannotti B, van Vloten WA, (eds) Basic Mechanisms of Physiologic and Aberrant Lymphoproliferation in the Skin. New York, Plenum Press, 1994, p 425
11. Rijlaarsdam JU, Van der Putte SCJ, Berti E, Kerl H, Rieger E, Toonstra J, Geerts ML, Meijer CJLM, Willemze R: Cutaneous immunocytomas: A clinicopathologic study of 26 cases. Histopathology 23:117, 1993
12. Willemze R, Beljaards RC, Meijer CJLM: Classification of primary cutaneous T-cell lymphoma. Histopathology 24:405, 1994
13. Noorduyn LA, Beljaards RC, Pals ST, van Heerde P, Radaszkiewicz T, Willemze R, Meijer CJLM: Differential expression of the HECA-452 antigen (cutaneous lymphocyte antigen, CLA) in cutaneous and noncutaneous T-cell lymphomas. Histopathology 21:59, 1992
14. Beljaards RC, Meijer CJLM, Scheffer E, Toonstra J, van Vloten WA, van der Putte SCJ, Geerts ML, Willemze R: Prognostic significance of CD30 (Ki-1/Ber-H2) expression of primary cutaneous large-cell lymphomas of T-cell origin. A clinicopathologic and immunohistochemical study in 20 patients. Am J Pathol 135:1169, 1989
15. Noorduyn LA, van der Valk P, van Heerde P, Vroom TM, Blok P, Willemze R, Meijer CJLM: Stage is a better prognostical indicator than morphological subtype in primary non-cutaneous T-cell lymphomas. Am J Clin Pathol 93:49, 1990
16. Hastrup N, Hamilton-Dutoit S, Ralfkiaer E, Pallesen G: Peripheral T-cell lymphomas; an evaluation of reproducibility of the updated Kiel classification. Histopathology 18:99, 1991
17. Willemze R, Beljaards RC: The spectrum of primary cutaneous CD30 (Ki-1) positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment. J Am Acad Dermatol 28:973, 1993
18. Paulli M, Bert E, Rosso R, Boveri E, Kindl S, Klersy C, Lazzarino M, Borroni G, Menestrina F, Santucci M, Gambini C, Vassallo G, Magrini U, Sterry W, Burg G, Geerts ML, Meijer CJLM, Willemze R, Feller AC, Müller-Hermelink HK, Kadin ME: CD30/ Ki-1-positive lymphoproliferative disorders of the skin. Clinicopathologic correlation and statistical analysis of 86 cases: A multicentric study from the EORTC cutaneous lymphoma project group. J Clin Oncol 13:1343, 1996
19. Willemze R, Meijer CJLM, van Vloten WA, Scheffer E: The clinical and histological spectrum of lymphomatoid papulosis. Br J Derm 107:131, 1982
20. Rijlaarsdam JU, Scheffer E, Meijer CJLM, Willemze R: Cutaneous pseudo-T-cell lymphomas. A clinicopathologic study of 20 patients. Cancer 69:717, 1992
21. Kerl H, Cerroni L, Burg G: The morphologic spectrum of T-cell lymphomas of the skin: A proposal for a new classification. Semin Diagnost Pathol 8:55, 1991
22. Willemze R, Beljaards RC, Meijer CJLM, Rijlaarsdam JU: Classification of primary cutaneous lymphomas. Dermatology 189:8, 1994 (suppl 2)
23. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Felini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
24. Burg G, Braun-Falco O: Cutaneous Lymphomas, Pseudolymphomas, and Related Disorders, Berlin, Springer-Verlag, 1983
25. Kerl H, Kresbach H: Lymphoreticuläre Hyperplasien und Neoplasien der Haut, in Doerr W, Seifert G, Uehlinger E (eds): Handbuch der Speziellen Pathologischen Anatomie und Histologie, vol 7/2, Berlin, Springer, 1979, p 351
26. Nickoloff BJ: Light-microscopic assessment of 100 patients with patch/plaque stage mycosis fungoides. Am J Dermatopathol 10:469, 1988
27. Smoller BR, Bishop K, Glusac E, Warnke R: Reassessment of histologic parameters in the diagnosis of mycosis fungoides. Am J Surg Pathol 19:1423, 1995
28. Ralfkiaer E: Immunohistochemical markers for the diagnosis of cutaneous lymphomas. Semin Diagnost Pathol 8:62, 1991
29. Wood GS, Tung RM, Haeffner AC, Crooks CF, Liao S, Orozco R, Veelken H, Kadin ME, Koh H, Heald P, Barnhill RL, Sklar J: Detection of clonal T-cell receptor γ gene rearrangements in early mycosis fungoides/Sézary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE). J Invest Dermatol 103:34, 1994
30. Wolff-Sneedorf A, Ralfkiaer E, Thomsen K, Vejlsgaard GL: Analysis of T-cell receptor β chain genes by Southern blotting in known and suspected cutaneous T-cell lymphomas. Clin Exp Dermatol 20:115, 1995
31. Pancake BA, Zucker-Franklin D, Coutavas EE: The cutaneous T-cell lymphoma, mycosis fungoides, is a human T cell lymphotropic virus-associated disease. J Clin Invest 95:547, 1995
32. Boni R, Daneschfar AD, Burg G, Fuchs D, Wood GS: No detection of HTLV-1 proviral DNA in lesional skin biopsies from Swiss and German patients with cutaneous T-cell lymphoma. Br J Dermatol 134:282, 1996
33. Li G, Vowels BR, Benoit BM, Rook AH, Lessin SR: Failure to detect human T-lymphotropic virus type I (HTLV-I) proviral DNA in cell lines and tissues from patients with cutaneous T-cell lymphoma. J Invest Dermatol 107:308, 1996
34. Herrmann JJ, Roenigk HH, Hurria A, Kuzel TM, Samuelson E, Rademaker AW, Rosen ST: Treatment of mycosis fungoides with photochemotherapy (PUVA): Long-term follow up. J Am Acad Dermatol 33:234, 1995
35. Vonderheid EC, Tan E, Kantor AF, Shrager L, Micaily B, Van Scott EJ: Long-term efficacy, curative potential and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T-cell lymphoma. J Am Acad Dermatol 20:416, 1989
36. Zackheim HS, Epstein EH, Crain WR: Topical carmustine (BCNU) for cutaneous T-cell lymphoma: A 15-year experience in 143 patients. J Am Acad Dermatol 22:802, 1990
37. Hoppe RT, Cox TS, Fuks Z, Price NM, Bagshaw MA, Farber EM: Electron-beam therapy for mycosis fungoides: The Stanford experience. Cancer Treat Rep 63:691, 1979
38. Kaye FJ, Bunn PA, Steinberg SM: A randomized trial comparing combination electron beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med 321:1784, 1989
39. Ross C, Tingsgaard P, Jørgensen H, Vejlsgaard GL: Interferon treatment of cutaneous T-cell lymphoma. Eur J Haematol 51:63, 1993
40. Cerroni L, Rieger E, Hödl S, Kerl H: Clinicopathologic and immunologic features associated with transformation of mycosis fungoides to large-cell lymphoma. Am J Surg Pathol 16:543, 1992
41. Dmitrovsky E, Matthews MJ, Bunn PA: Cytologic transformation in cutaneous T-cell lymphoma. A ctinicopathologic entity asociated with a poor prognosis. J Clin Oncol 5:208, 1987
42. Sentis HJ, Willemze R, Scheffer E: Alopecia mucinosa progressing into mycosis fungoides. Am J Dermatopathol 10:478, 1988
43. Gibson LE, Muller SA, Leiferman KM, Peters MS: Follicular mucinosis. J Am Acad Dermatol 20:441, 1989
44. Nickoloff BJ, Wood C: Benign idiopathic versus mycosis fungoides-associated follicular mucinosis. Pediatr Dermatol 2:201, 1985
45. Vergier B, Beylot-Barry M, Beylot C, de Mascarel A, Delaunay M, de Muret A, Vaillant L, Tortel MC, Grange F, Bagot M, Laroche L, Wechsler J: Pilotropic cutaneous T-cell lymphoma without mucinosis. A variant of mycosis fungoides? Arch Dermatol 132:683, 1996
46. Zelickson BD, Peters MS, Muller SA, Thibodeau SN, Lust JA, Quam LM, Pittelkow MR: T-cell receptor gene rearrangement analysis: Cutaneous T-cell lymphoma, peripheral T-cell lymphoma, and premalignant and benign cutaneous lymphoproliferative disorders. J Am Acad Dermatol 25:787, 1991
47. Braun-Falco O, Marghescu S, Wolff HH: Pagetoide retikulose: Morbus Woringer-Kolopp. Hautarzt 24:11, 1973
48. Mielke V, Wolff HH, Winzer M, Sterry W: Localized and disseminated pagetoid reticulosis. Arch Dermatol 125:402, 1989
49. Burns MK, Chan LS, Cooper KD: Woringer-Kolopp disease (localized pagetoid reticulosis) or unilesional mycosis fungoides? Arch Dermatol 131:325, 1995
50. Wood GS, Weiss LM, Hu CH, Abel EA, Hoppe RT, Warnke RA, Sklar J: T-cell antigen deficiencies and clonal rearrangements of T-cell receptor genes in pagetoid reticulosis (Woringer-Kolopp disease). N Engl J Med 318:164, 1988
51. + cutaneous lymphomas. Curr Probl Dermatol 19:132, 1990
52. Sioutos N, Kerl H, Murphy SB, Kadin ME: Primary cutaneous Hodgkin's disease. Am J Dermatopathol 16:2, 1994
53. Beljaards RC, Meijer CJLM, van der Putte SCJ, Hollema H, Geerts ML, Bezemer PD, Willemze R: Primary cutaneous T-cell lymphomas. Clinicopathologic features and prognostic parameters of 35 cases other than mycosis fungoides and CD30-positive large cell lymphoma. J Pathol 172:53, 1994
54. Banerjee SS, Heald J, Harris M: Twelve cases of Ki-1 positive anaplastic large cell lymphoma of the skin. J Clin Pathol 44:119, 1991
55. Gianotti R, Alessi E, Cavicchini S, Berti E: Primary cutaneous pleomorphic T-cell lymphoma expressing CD30 antigen. Am J Dermatopathol 13:503, 1991
56. de Bruin PC, Beljaards RC, van Heerde P, van der Valk P, Noorduyn LA, van Krieken JHJM, Kluin-Nelemans JC, Willemze R, Meijer CJLM: Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype. Histopathology 23:127, 1993
57. De Coteau JF, Butmarc JR, Kinney MC, Kadin ME: The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30 + lymphoproliferative disorders: Comparison with anaplastic large-cell lymphoma of nodal origin. Blood 87:3437, 1996
58. Beylot-Barry M, Lamant L, Vergier B, de Muret A, Fraitag S, Delord B, Dubus P, Vaillant L, Delaunay M, Mac Grogan G, Beylot C, de Mascaret A, Delsol G, Merlio JP: Detection of t(25)(p23;q35) translocation by reverse transcriptase polymerase chain reaction and in situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosis. Am J Pathol 149:483, 1996
59. MacCaulay WL: Lymphomatoid papulosis. A continuing self-healing eruption, clinically benign-histologically malignant. Arch Dermatol 97:23, 1968
60. Willemze R: Lymphomatoid papulosis. Dermatol Clin 3:735, 1985
61. Beljaards RC, Willemze R: The prognosis of patients with lymphomatoid papulosis associated with malignant lymphomas. Br J Demiatol 126:126, 1992
62. Kaudewitz P, Stein H, Burg G, Mason DY, Braun-Falco O: Atypical cells in lymphomatoid papulosis express the Hodgkin cell associated antigen-Ki-1. J Invest Dermatol 86:350, 1986
63. Kadin M, Nasu K, Sako D: Lymphomatoid papulosis, a cutaneous proliferation of activated helper T cells expressing Hodgkin's disease associated antigens. Am J Pathol 119:315, 1985
64. Whittaker S, Smith N, Russell Jones R, Luzzatto L: Analysis of β, γ and δ T-cell receptor genes in lymphomatoid papulosis: Cellular basis of two distinct histologic subsets. J Invest Dermatol 96:786, 1991
65. Davis TM, Morton CC, Miller-Cassman R, Balk SP, Kadin ME: Hodgkin's disease, lymphomatoid papulosis and cutaneous T-cell lymphoma derived from a common T-cell clone. N Engl J Med 326:1115, 1992
66. Vonderheid EC, Sajjadian A, Kadin ME: Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders. J Am Acad Dermatol 34:470, 1996
67. Sézary A, Bouvrain Y: Erythrodermie avec presence de cellules monstrueuses dans le derme et dans le sang circulant. Bull Soc Fr Dermatol Syph 45:254, 1983
68. Wieselthier JS, Koh HK: Sézary syndrome: Diagnosis, prognosis, and critical review of treatment options. J Am Acad Dermatol 22:381, 1990
69. Buechner SA, Winkelmann RK: Sézary syndrome: A clinicopathologic study of 39 cases. Arch Dermatol 119:979, 1983
70. Sentis HJ, Willemze R, Scheffer E: Histopathologic studies in Sézary syndrome and erythrodermic mycosis fungoides: A comparison with benign forms of erythroderma. J Am Acad Dermatol 15:1217, 1986
71. Scheffer E, Meijer CJLM, van Vloten WA, Willemze R: A histological study of lymph nodes from patients with the Sézary's syndrome. Cancer 57:2375, 1986
72. Willemze R, van Vloten WA, Hermans J, Damsteeg WJM, Meijer CJLM: Diagnostic criteria in Sézary's syndrome. A multiparameter study of peripheral blood lymphocytes in 32 patients with erythroderma. J Invest Dermatol 81:392, 1983
73. Bakels V, van Oostveen JW, Gordijn RLJ, Walboomers JMM, Meijer CJLM, Willemze R: Diagnostic value of T-cell receptor beta gene rearrangement analysis on peripheral blood lymphocytes of patients with erythroderma. J Invest Dermatol 97:782, 1991
74. Zackheim HS, Kashani-Sabet M, Hwang ST: Low-dose methotrexate to treat erythrodermic cutaneous T-cell lymphoma: Results in twenty-nine patients. J Am Acad Dermatol 34:626, 1996
75. Winkelmann RK, Diaz-Perez JL, Buechner SA: The treatment of Sézary syndrome. J Am Acad Dermatol 10:1000, 1984
76. Heald P, Rook A, Perez M: Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy. J Am Acad Dermatol 27:427, 1992
77. Sterry W, Siebel A, Mielke V: HTLV1-negative pleomorphic T-cell lymphoma of the skin. The clinicopathologic correlations and natural history of 15 patients. Br J Dermatol 126:456, 1992
78. Chan JKC, Ng CS, Ngan KC, Hui PK, Lo STH, Lau WH: Angiocentric T-cell lymphoma of the skin. An aggressive lymphoma distinct from mycosis fungoides. Am J Surg Pathol 12:861, 1988
79. Su IJ, Wang YC, Chen YC, Hsieh HC, Cheng AL, Wang CH, Kadin ME: Cutaneous manifestations of postthymic malignancies. Descriptions of five clinicopathologic subtypes. J Am Acad Dermatol 23:653, 1990
80. Wechsler J, Bagot M, Willemze R, van der Brule A, Thomine E, Joly P, Verola O, Bachelet H, Fonck Y, Souteyrand P, Parcet JP, Gaulard P: Epstein-Barr virus (EBV) genomes and EBV-encoded latent membrane protein in cutaneous angiocentric lymphomas. Arch Dermatol (in press)
81. LeBoit PE, Beckstead JH, Bond B, Epstein WL, Frieden IJ, Parslow TG: Granulomatous slack skin. Clonal rearrangements of the T-cell receptor β gene is evidence for the lymphoproliferative nature of a cutaneous elastolytic disorder. J Invest Dermatol 89:183, 1987
82. LeBoit PE: Granulomatous slack skin. Dermatol Clin 12:375, 1994
83. Mouly F, Baccard M, Cayuela JM, Janssen F, Verola O, Flageul B, Morel P: Cutaneous T-cell lymphoma associated with granulomatous slack skin. Dermatology 192:288, 1996
84. Friedmann D, Wechsler J, Delfau MH, Estève E, Farcet JP, de Muret A, Parneix-Spake A, Vaillant L, Revuz J, Bagot M: Primary cutaneous pleomorphic small T-cell lymphoma. Arch Dermatol 131:1009, 1995
85. Bakels V, van Oostveen JW, van der Putte CJ, Meijer CJLM, Willemze R: Immunophenotyping and gene rearrangement analysis provide additional criteria to differentiate between cutaneous T-cell lymphomas and pseudo-T-cell lymphomas. Am J Pathol 1997 (in press)
86. Agnarsson BA, Vonderheid EC, Kadin ME: Cutaneous T-cell lymphoma with suppressor/cytotoxic (CDS) phenotype: Identification of rapidly progressive and chronic subtypes. J Am Acad Dermatol 22:569, 1990
87. Urrutia S, Piris MA, Orradre JL, Martinez B, Cruz MA, Garcia-Almagro D: Cytotoxic/suppressor (CD8+, CD4-) cutaneous T-cell lymphoma with aggressive course. Am J Dermatopathol 12:603, 1990
88. Gonzalez CL, Medeiros LJ, Braziel RM, Jaffe ES: T-cell lymphoma involving subcutaneous tissue. A clinicopathologic entity commonly associated with hemophagocytic syndrome. Am J Surg Pathol 15:17, 1991
89. Wang CE, Su WPD, Kurtin PJ: Subcutaneous panniculitic T-cell lymphoma. Int J Dermatol 35:1, 1996
90. Chan JKC, Tsang WYW, Lo ESF: Cutaneous angiocentric T-cell lymphoma and subcutaneous panniculitic T-cell lymphoma are distinct entities. Mod Pathol 9:109, 1996
91. Burg G, Dummer R, Wilhelm M, Nestle F, Ott MM, Feller A, Hefner H, Lanz U, Schwinn A, Wiede J: A subcutaneous delta-positive T-cell lymphoma that produces interferon gamma. N Engl J Med 325:1078, 1991
92. Avinoach I, Halevy S, Argov S, Sacks M: γ/δ T-cell lymphoma involving the subcutaneous tissue and associated with a hemophagocytic syndrome. Am J Dermatopathol 16:426, 1994
93. Willemze R, Meijer CJLM, Sentis HJ, Scheffer E, van Vloten WA, Toonstra J, van der Putte SCJ: Primary cutaneous large cell lymphomas of follicular center cell origin. J Am Acad Dermatol 16:518, 1987
94. Garcia CF, Weiss LM, Warnke RA, Wood G: Cutaneous follicular lymphoma. Am J Surg Pathol 10:454, 1986
95. Berti E, Alessi E, Caputo R, Gianotti R, Delia D, Vezzoni P: Reticulohistiocytoma of the dorsum. J Am Acad Dermatol 19:259, 1988
96. Santucci M, Pimpinelli N, Arganini L: Primary cutaneous B-cell lymphoma: A unique type of low-grade lymphoma: Clinicopathologic and immunologic study of 83 cases. Cancer 67:2311, 1991
97. Rijlaarsdam JU, Bakels V, van Oostveen JW, Gordijn RJL, Geerts ML, Meijer CJLM, Willemze R: Demonstration of clonal immunoglobulin gene rearrangements in cutaneous B-cell lymphomas and pseudo-B-cell lymphomas: Differential diagnostic and pathogenetic aspects. J Invest Dermatol 99:749, 1992
98. Cerroni L, Volkenandt M, Rieger E, Soyer P, Kerl H: bcl-2 protein expression and correlation with the interchromosomal 14; 18 translocation in cutaneous lymphomas and pseudolymphomas. J Invest Dermatol 102:231, 1994
99. Piccinno R, Caccialanza M, Berti E, Baldini L: Radiotherapy of cutaneous B cell lymphomas: Our experience in 31 cases. Int J Radiat Oncol Biol Phys 27:385, 1993
100. Rijlaarsdam JU, Toonstra J, Meijer OWM, Noordijk EM, Willemze R: Treatment of primary cutaneous B-cell lymphomas of follicular center cell origin. A clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy. J Clin Oncol 14:549, 1996
101. Slater DN: MALT and SALT: The clue to cutaneous B-cell lymphoproliferative disease. Br J Dermatol 131:557, 1994
102. Vermeer MH, Geelen FAMJ, van Haselen CW, van Voorst Vader PC, Geerts ML, van Vloten WA, Willemze R: Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Arch Dermatol 132:1304, 1996
103. Guggenberger K, Burg G, Schmoeckel C, Detmar U: Follow-ups in cutaneous immunocytomas, in Goos M, Christophers E (eds): in Lymphoproliferative Diseases of the Skin. Berlin, Springer-Verlag, 1982, p 192
104. Van der Putte SCJ, De Kreek EJ, Go DMDS, van Unnik JAM: Primary cutaneous lymphoplasmacytoid lymphoma (immunocytoma). Am J Dermatopathol 6:15, 1984
105. Braun-Falco O, Guggenberger K, Burg G: Immunonozytom unter dem Bild einer Acrodermatitis chronica atrophicans. Hautartz 29:644, 1978
106. Mayou SC, Cotter FE, Norton AJ, Davies CL, Munro DD: A cutaneous B-cell lymphoma of novel immunophenotype. Br J Dermatol 125:373, 1991
107. Bailey EM, Ferry JA, Harris NL, Mihm MC, Jacobson JO, Duncan LM: Marginal zone lymphoma (low-grade B-cell lymphoma) of mucosa-associated lymphoid tissue type) of skin and subcutaneous tissue. Am J Surg Pathol 20:1011, 1996
108. Garbe C, Stein H, Dienemann D, Orfanos CE: Borrelia burgdorferi associated cutaneous B cell lymphoma: Clinical and immunohistochemical characterization of four cases. J Am Acad Dermatol 24:584, 1991
109. Geelen FAMJ, Beljaards RC, van der Putte SCJ, Willemze R: Differences in the expression of bcl-2 protein and adhesion molecules between prognostically different groups of primary cutaneous large B-cell lymphomas. Ann Oncol 7:132, 1996 (suppl 3)
110. Tappeiner J, Pfleger L: Angioendotheliomatosis proliferans systemisata. Ein klinisch und pathologisch neues Krankheitsbild. Hautarzt 14:67, 1959
111. Wick MR, Mills SE, Scheithauer BW, Cooper PH, Davitz MA, Parkinson K: Reassessment of malignant "angioendotheliomatosis." Evidence in favor of its reclassification as "intravascular lymphomatosis." Am J Surg Pathol 10:112, 1986
112. Willemze R, Kruyswijk MRJ, De Bruin CD, Meijer CJLM, van Berkel W: Angiotropic (intravascular) large cell lymphoma of the skin previously classified as malignant angioendotheliomatosis. Br J Dermatol 116:393, 1987
113. Perniciaro C, Winkelmann RK, Daoud MS, Su WPD: Malignant angioendotheliomatosis is an angiotropic intravascular lymphoma. Am J Dermatopathol 17:242, 1995
114. Wick MR, Mills SE: Intravascular lymphomatosis: Clinicopathologic features and differential diagnosis. Semin Diagnost Pathol 8:91, 1991
115. Torne R, Su WPD, Winkelmann RK, Smolle J, Kerl H: Clinicopathologic study of cutaneous plasmacytoma. Int J Dermatol 29:562, 1990
116. Walker E, Robertson AG, Boorman JG, McNicol AM: Primary cutaneous plasmacytoma: The use of in situ hybridization to detect monoclonal immunoglobulin light chain mRNA. Histopathology 20:135, 1992
117. Llamas-Martin R, Postigo-Llorente C, Vanaclocha-Sebastian F, Gil-Martin R, Iglesias-Diez L: Primary cutaneous extramedullary plasmacytoma secreting X IgG. Clin Exp Dermatol 18:351, 1993
118. Chang YT, Wong CK: Primary cutaneous plasmacytomas. Clin Exp Dermatol 19:177, 1994
119. Wiltshaw E: The natural history of extramedullary plasmacytoma and its relation to solitary myeloma of bone and myelomatosis. Medicine 553:217, 1976
120. Kugelman LC, Smith BR, Buckley P, Katz ME, Edelson R: Lymphoproliferative disease of granular lymphocytes. J Am Acad Dermatol 32:829, 1995
121. Barzilai A, Goldberg I, Shibi R, Kopolovic J, Trau H: MF expressing a γ/δ T-cell receptors. J Am Acad Dermatol 34:301, 1996
122. Berti E, Cerri A, Cavicchini S, Delia D, Soligo D, Alessi E, Caputo R: Primary cutaneous gamma/delta T-cell lymphoma presenting as disseminated pagetoid reticulosis. J Invest Dermatol 96:718, 1991
123. Ralfkiaer E, Wollf-Sneedorff A, Thomsen K, Geisler C, Vejlsgaard GL: T-cell receptor gamma delta-positive peripheral T-cell lymphornas presenting in the skin: A clinical histological and immunophenotypic study. Exp Dermatol 1:31, 1992
124. Munn SE, McGregor JM, Jones A, Amlot P, Rustin MHA, Russell-Jones R, Whittaker S: Clinical and pathological heterogeneity in cutaneous gamma-delta T-cell lymphoma: A report of three cases and a review of the literature. Br J Dermatol 135:976, 1996
125. Geerts ML, Busschots A: Mantle-cell lymphomas of the skin. Dermatol Clin 12:409, 1994
126. Bertero M, Novelli M, Fierro MT, Bernengo MG: Mantle zone lymphoma: An immunohistochemical study of skin lesions. J Am Acad Dermatol 30:23, 1994
127. Lennert K, Feller AC: Non-Hodgkin's Lymphomas, 2nd ed (based on the updated Kiel classification). Berlin, Springer-Verlag, 1990
128. Sander CA, Kaudewitz P, Schirren CG, Jaffe ES, Kind P: Immunocytoma and marginal zone B-cell lymphoma (MALT lymphoma) presenting in skin - different entities or a spectrum of disease? J Cutan Pathol 23:59, 1996
129. Kerl H, Cerroni L: The morphologic spectrum of cutaneous B-cell lymphomas. Arch Dermatol 132:1376, 1996
130. Willemze R, Meijer CJLM, Rijlaarsdam JU, Meijer CJLM: Are most primary cutaneous B-cell lymphomas "marginal cell lymphomas"? Br J Dermatol 133:950, 1995